Martyn Jacobs
Stock Analyst at Bell Potter
(0.04)
# 4,502
Out of 4,516 analysts
178
Total ratings
16.7%
Success rate
-19.7%
Average return
Main Sectors:
Stocks Rated by Martyn Jacobs
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: EMV EMVision Medical Devices Ltd | Maintained: Buy | $3.15 | $1.68 | +87.50% | 9 | Jul 16, 2026 | |
| ASX: LDX Lumos Diagnostics Holdings Limited | Maintained: Buy | $0.08 | $0.09 | -8.05% | 1 | Jul 15, 2026 | |
| ASX: BIO Biome Australia Limited | Maintained: Buy | $1.00 → $0.75 | $0.28 | +167.86% | 18 | Jul 2, 2026 | |
| ASX: VFY Vitrafy Life Sciences Limited | Maintained: Buy | $3.00 → $5.15 | $2.80 | +83.93% | 10 | Jun 24, 2026 | |
| ASX: MVF Monash IVF Group Limited | Maintained: Hold | $0.77 → $0.75 | $0.71 | +6.38% | 7 | Jun 14, 2026 | |
| ASX: EBR EBR Systems, Inc. | Maintained: Buy | $1.87 → $2.00 | $0.38 | +433.33% | 17 | Jun 5, 2026 | |
| ASX: SHL Sonic Healthcare Limited | Maintained: Buy | $28.75 | $21.65 | +32.79% | 5 | Jun 3, 2026 | |
| ASX: IDX Integral Diagnostics Limited | Maintained: Buy | $3.80 | $2.13 | +78.40% | 7 | Jun 3, 2026 | |
| ASX: AHC Austco Healthcare Limited | Maintained: Buy | $0.55 → $0.45 | $0.24 | +89.87% | 4 | Jun 1, 2026 | |
| ASX: AYA Artrya Limited | Maintained: Buy | $6.10 | $5.76 | +5.90% | 3 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.05 → $0.75 | $0.27 | +177.78% | 15 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.03 → $0.01 | $0.01 | +66.67% | 14 | May 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.45 | $0.17 | +172.73% | 9 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.85 | $0.40 | +112.50% | 14 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.92 | n/a | 11 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.01 | n/a | 2 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.22 | n/a | 12 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.064 | n/a | 7 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.017 | n/a | 7 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.115 | n/a | 4 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.041 | n/a | 2 | Oct 31, 2022 |
EMVision Medical Devices Ltd
Jul 16, 2026
Maintained: Buy
Price Target: $3.15
Current: $1.68
Upside: +87.50%
Lumos Diagnostics Holdings Limited
Jul 15, 2026
Maintained: Buy
Price Target: $0.08
Current: $0.09
Upside: -8.05%
Biome Australia Limited
Jul 2, 2026
Maintained: Buy
Price Target: $1.00 → $0.75
Current: $0.28
Upside: +167.86%
Vitrafy Life Sciences Limited
Jun 24, 2026
Maintained: Buy
Price Target: $3.00 → $5.15
Current: $2.80
Upside: +83.93%
Monash IVF Group Limited
Jun 14, 2026
Maintained: Hold
Price Target: $0.77 → $0.75
Current: $0.71
Upside: +6.38%
EBR Systems, Inc.
Jun 5, 2026
Maintained: Buy
Price Target: $1.87 → $2.00
Current: $0.38
Upside: +433.33%
Sonic Healthcare Limited
Jun 3, 2026
Maintained: Buy
Price Target: $28.75
Current: $21.65
Upside: +32.79%
Integral Diagnostics Limited
Jun 3, 2026
Maintained: Buy
Price Target: $3.80
Current: $2.13
Upside: +78.40%
Austco Healthcare Limited
Jun 1, 2026
Maintained: Buy
Price Target: $0.55 → $0.45
Current: $0.24
Upside: +89.87%
Artrya Limited
Jun 1, 2026
Maintained: Buy
Price Target: $6.10
Current: $5.76
Upside: +5.90%
May 27, 2026
Maintained: Buy
Price Target: $1.05 → $0.75
Current: $0.27
Upside: +177.78%
May 10, 2026
Maintained: Buy
Price Target: $0.03 → $0.01
Current: $0.01
Upside: +66.67%
Apr 27, 2026
Maintained: Buy
Price Target: $0.45
Current: $0.17
Upside: +172.73%
Apr 27, 2026
Maintained: Buy
Price Target: $0.85
Current: $0.40
Upside: +112.50%
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $2.92
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $0.01
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $3.22
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $0.064
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $0.017
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $0.115
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $0.041
Upside: n/a